← Back to Search

Antiperspirant

Aluminum Chloride 20% (deodorant) for Excessive Sweating

Phase 1
Waitlist Available
Led By Colby Hansen, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial is testing the effectiveness of a prescription strength topical antiperspirant on hyperhidrosis of the residual limb in amputees. The hypothesis is that Aluminum Chloride will be more effective at controlling sweating than placebo.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Hyperhidrosis Disease Severity Scale (HDSS)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Aluminum Chloride vs Placebo in AmputeesActive Control2 Interventions
Aim 2: The investigators will have completed the first clinical trial of Aluminum Chloride for residual limb hyperhidrosis. The investigators will then have a solid foundation of data that demonstrates the rates of adverse effects such as skin irritation, and rates and magnitudes of improvement in subjective and objective measures of sweating.
Group II: Placebo Comparator AIM 1Placebo Group2 Interventions
Aim 1: Demonstration of a strong association of the Sweating Intensity Visual Scale (SIVS) score with the HDSS would provide validation for use of the SIVS in interpreting the iodine-starch test and would establish the value of the iodine-starch test in clinical practice guidelines for diagnosing hyperhidrosis in amputees, just as it is in dermatology practice.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,594 Total Patients Enrolled
US Department of Veterans AffairsFED
868 Previous Clinical Trials
487,795 Total Patients Enrolled
U.S. Army Medical Research and Development CommandFED
286 Previous Clinical Trials
245,664 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
Colby Hansen 2018. "Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03416348.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top